App Reminder on ASA Adherence
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 10/13/2018 |
| Start Date: | October 3, 2017 |
| End Date: | April 24, 2020 |
| Contact: | Deborah Wittig-Wells, PhD |
| Email: | deborah.wittig-wells@emory.edu |
| Phone: | 704-300-7043 |
Impact of a Smartphone App Reminder on Adherence Aspirin Prescribed as Anti-Thrombotic Therapy
The purpose of this study is to explore the impact of using a smartphone app reminder on
medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as
anti-thrombotic therapy after knee or hip arthroplasty.
This study will randomly assign participants to get usual postoperative care which is
teaching with verbal instructions and printed information about taking the aspirin at the
time of discharge, or to have an app on your smartphone with preset reminders in addition to
usual postoperative discharge teaching after surgery.
medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as
anti-thrombotic therapy after knee or hip arthroplasty.
This study will randomly assign participants to get usual postoperative care which is
teaching with verbal instructions and printed information about taking the aspirin at the
time of discharge, or to have an app on your smartphone with preset reminders in addition to
usual postoperative discharge teaching after surgery.
The purpose of this study is to evaluate the impact of using a smartphone application (app)
reminder on medication adherence twice daily in 200 adults prescribed 81 milligrams of
aspirin (ASA) for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. The aim
is to determine if an app downloaded on a smartphone that reminds patients twice a day to
take their ASA as prescribed will improve ASA adherence and clinical outcomes for patients
after total knee and total hip joint arthroplasty compared to those in the usual care.
This is a two group, randomized control study with random assignment into the control group
for usual care or the intervention group to receive a medication reminder app for their smart
phone (daily for 35 days) plus usual care. Participants will receive a baseline interview for
demographic and other data and 36 day follow-up assessment, both conducted in person.
reminder on medication adherence twice daily in 200 adults prescribed 81 milligrams of
aspirin (ASA) for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. The aim
is to determine if an app downloaded on a smartphone that reminds patients twice a day to
take their ASA as prescribed will improve ASA adherence and clinical outcomes for patients
after total knee and total hip joint arthroplasty compared to those in the usual care.
This is a two group, randomized control study with random assignment into the control group
for usual care or the intervention group to receive a medication reminder app for their smart
phone (daily for 35 days) plus usual care. Participants will receive a baseline interview for
demographic and other data and 36 day follow-up assessment, both conducted in person.
Inclusion Criteria:
- Prescribed aspirin 81 mg twice a day for 35 days
- Ability to write and speak English
- Have a smart phone with the capacity to download and set an app
- Own and use a smart phone for communication purposes
Exclusion Criteria:
- Diagnosis of mental illness
- Do not own a smart phone
We found this trial at
1
site
Click here to add this to my saved trials
